NCAM1 and acute lymphoblastic leukemia: In conclusion, the decreasing levels of CD1d on monocytes may contribute to AML and ALL progression, as a correlation was observed between the levels of CD1d on monocytes and the number/cytotoxicity of CD3+CD56+ T lymphocytes in AML and ALL patients.